# Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

> **NCT02207595** · PHASE1 · COMPLETED · sponsor: **UCB Celltech** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** UCB5857
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02207595
- **Lead sponsor:** UCB Celltech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207595, "Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02207595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*